Klaria Pharma Holding Overview
- Year Founded
-
2015

- Status
-
Public
- Employees
-
4

- Stock Symbol
-
KLAR

- Investments
-
3
- Share Price
-
$0.04
- (As of Wednesday Closing)
Klaria Pharma Holding General Information
Description
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
Contact Information
Website
www.klaria.comCorporate Office
- Virdings Allé 2
- 754 50 Uppsala
- Sweden
Corporate Office
- Virdings Allé 2
- 754 50 Uppsala
- Sweden
Klaria Pharma Holding Stock Performance
As of 18-Jun-2025, Klaria Pharma Holding’s stock price is $0.04. Its current market cap is $6.36M with 149M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.04 | $0.04 | $0.02 - $0.17 | $6.36M | 149M | 507K | -$0.04 |
Klaria Pharma Holding Financials Summary
As of 31-Dec-2024, Klaria Pharma Holding has a trailing 12-month revenue of $213K.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 3,886 | 3,886 | 4,715 | 5,847 |
Revenue | 213 | 213 | 795 | 578 |
EBITDA | (1,904) | (1,904) | (1,990) | (4,416) |
Net Income | (4,515) | (4,515) | (3,367) | (6,286) |
Total Assets | 5,190 | 5,190 | 7,299 | 11,529 |
Total Debt | 2,091 | 2,091 | 1,929 | 1,638 |
Klaria Pharma Holding Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Klaria Pharma Holding Patents
Klaria Pharma Holding Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-201912505-D0 | Pharmaceutical formulation | Inactive | 30-Aug-2019 | ||
AU-2020338697-A1 | Pharmaceutical formulation | Inactive | 30-Aug-2019 | ||
EP-4021405-A1 | Pharmaceutical formulation | Active | 30-Aug-2019 | ||
US-20220280453-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | ||
CA-3146475-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | A61K9/7007 |
Klaria Pharma Holding Signals
Klaria Pharma Holding Acquisitions (3)
Klaria Pharma Holding’s most recent deal was a Merger/Acquisition with Karessa Pharma Holding for . The deal was made on 06-Mar-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Karessa Pharma Holding | 06-Mar-2020 | Merger/Acquisition | Drug Delivery | ||
Uppsalagruppen Medical | 05-Nov-2019 | Merger/Acquisition | Drug Delivery | ||
WBC Technologies | 19-Sep-2019 | Merger/Acquisition | Drug Delivery |
Klaria Pharma Holding Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
WBC Technologies | Munich, Germany | 2019 | |
Uppsalagruppen Medical | Uppsala, Sweden | 2011 |
Klaria Pharma Holding FAQs
-
When was Klaria Pharma Holding founded?
Klaria Pharma Holding was founded in 2015.
-
Where is Klaria Pharma Holding headquartered?
Klaria Pharma Holding is headquartered in Uppsala, Sweden.
-
What is the size of Klaria Pharma Holding?
Klaria Pharma Holding has 4 total employees.
-
What industry is Klaria Pharma Holding in?
Klaria Pharma Holding’s primary industry is Drug Delivery.
-
Is Klaria Pharma Holding a private or public company?
Klaria Pharma Holding is a Public company.
-
What is Klaria Pharma Holding’s stock symbol?
The ticker symbol for Klaria Pharma Holding is KLAR.
-
What is the current stock price of Klaria Pharma Holding?
As of 18-Jun-2025 the stock price of Klaria Pharma Holding is $0.04.
-
What is the current market cap of Klaria Pharma Holding?
The current market capitalization of Klaria Pharma Holding is $6.36M.
-
What is Klaria Pharma Holding’s current revenue?
The trailing twelve month revenue for Klaria Pharma Holding is $213K.
-
What is Klaria Pharma Holding’s annual earnings per share (EPS)?
Klaria Pharma Holding’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »